• en
  • it
  • RESERVED AREA
  • CONTACTS
  • BIOMEDICA FOSCAMA
    • Who we are
    • Vision and values
    • The Group
    • Quality and sustainability
  • PRODUCTION
    • Lyophilized products
    • Injectable Products in ampoules
    • Injectable products in vials
    • Visual Inspection and packaging
  • VACCINES
  • R&D
  • PRODUCTS
    • Esafosphine
    • Tad
    • Food Supplements
  • DISTRIBUTION AND EXPORT
  • NEWS
Home » News

News

14 October 2021

Biomedica Foscama tra le aziende apripista sui vaccini Covid-19

14 October 2021

Covid e vaccini: la lotta la virus passa per la Ciociaria. Biomedica Foscama tra le aziende interessate

14 October 2021

Un’interessante studio preclinico sulla relazione tra Glutatione e COVID-19

Head office:
Via Morolense, 87
03013 Ferentino (FR)

TAX code and VAT number : 11196811001
Chamber of commerce, industry, handicrafts and agriculture of Frosinone
REA number: FR 178103
Share capital: € 1.000.000,00 i.v.
Registered email address : sp.lab@legalmail.it

Privacy Policy

Review your cookie choices

  • Contacts
  • Privacy e Cookie Policy
  • The pharmacovigilance
  • General Purchase Conditions
  • General Purchase Conditions for sale

News

  • Biomedica Foscama tra le aziende apripista sui vaccini Covid-19
  • Covid e vaccini: la lotta la virus passa per la Ciociaria. Biomedica F…
© 2023 Biomedica Foscama S.p.a.
Designed and developed by Dueper Design - Powered by Mactelab
  • BIOMEDICA FOSCAMA
    • Who we are
    • Vision and values
    • The Group
    • Quality and sustainability
  • PRODUCTION
    • Lyophilized products
    • Injectable Products in ampoules
    • Injectable products in vials
    • Visual Inspection and packaging
  • VACCINES
  • R&D
  • PRODUCTS
    • Esafosphine
    • Tad
    • Food Supplements
  • DISTRIBUTION AND EXPORT
  • RESERVED AREA
  • CONTACTS